Charles R. Esther, Denise A

Slides:



Advertisements
Similar presentations
Prevalence and antimicrobial susceptibility of microorganisms isolated from sputa of patients with cystic fibrosis  Giuseppe Valenza, Dennis Tappe, Doris.
Advertisements

Mycobacterium avium and Mycobacterium abscessus complex target distinct cystic fibrosis patient subpopulations  Emilie Catherinot, Anne-Laure Roux, Marie-Anne.
Comparing age of cystic fibrosis diagnosis and treatment initiation after newborn screening with two common strategies  Don B. Sanders, Huichuan J. Lai,
Effect of dornase alfa on inflammation and lung function: Potential role in the early treatment of cystic fibrosis  Michael W. Konstan, Felix Ratjen 
Achromobacter species in cystic fibrosis: Cross-infection caused by indirect patient-to- patient contact  C.R. Hansen, T. Pressler, W. Ridderberg, H.K.
Prevalence and impact on FEV1 decline of chronic methicillin-resistant Staphylococcus aureus (MRSA) colonization in patients with Cystic Fibrosis  E.
Zhumin Zhang, Suzanne M. Shoff, HuiChuan J. Lai 
Comparing Mycobacterium massiliense and Mycobacterium abscessus lung infections in cystic fibrosis patients  Anne-Laure Roux, Emilie Catherinot, Nathalie.
Infections in Patients with Cystic Fibrosis
Is infection with hypermutable Pseudomonas aeruginosa clinically significant?  Adi Auerbach, Eitan Kerem, Marc Victor Assous, Elie Picard, Maskit Bar-Meir 
Development, validation, and implementation of a questionnaire assessing disease knowledge and understanding in adult cystic fibrosis patients  Karen.
How does heart rate recovery after sub-maximal exercise correlate with maximal exercise testing in children with CF?  Sarah P. Cohen, David M. Orenstein 
Chlamydia trachomatis infections in heterosexuals attending sexually transmitted disease clinics in Slovenia  D. Kese, M. Maticic, M. Potocnik  Clinical.
Nadav Traeger, Qiuhu Shi, Allen J. Dozor  Journal of Cystic Fibrosis 
Measures of body habitus are associated with lung function in adults with cystic fibrosis: A population-based study  Doug L. Forrester, Alan J. Knox,
Laura Viviani, Baroukh M. Assael, Eitan Kerem 
Eradication of chronic methicillin-resistant Staphylococcus aureus infection in cystic fibrosis patients. An observational prospective cohort study of.
A longitudinal analysis of chronic MRSA and Pseudomonas aeruginosa co-infection in cystic fibrosis: A single-center study  Maret L. Maliniak, Arlene A.
Cirrhosis and other liver disease in cystic fibrosis
Katelyn Krivchenia, Don Hayes, Joseph D. Tobias, Dmitry Tumin 
Lung transplantation in patients with cystic fibrosis and Mycobacterium abscessus infection  Marita Gilljam, Henrik Scherstén, Martin Silverborn, Bodil.
Increased serum concentration of G-CSF in cystic fibrosis patients with chronic Pseudomonas aeruginosa pneumonia  P.Ø. Jensen, C. Moser, A. Kharazmi,
A. Oliver, A. Mena  Clinical Microbiology and Infection 
Increasing nontuberculous mycobacteria infection in cystic fibrosis
Clinical outcomes in cystic fibrosis patients with Trichosporon respiratory infection  Charles R. Esther, Rongpong Plongla, Alan Kerr, Feng-Chang Lin,
Factors associated with subsequent nontuberculous mycobacterial lung disease in patients with a single sputum isolate on initial examination  M.-R. Lee,
Long-term azitromycin treatment of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection; an observational cohort study  Christine Rønne.
Rapidly growing mycobacteria in Singapore, 2006–2011
Comparing the harmful effects of nontuberculous mycobacteria and Gram negative bacteria on lung function in patients with cystic fibrosis  Tavs Qvist,
Asians with cystic fibrosis in the UK have worse disease outcomes than clinic matched white homozygous ΔF508 controls  Jonathan McCormick, Simon A. Ogston,
Exercise-induced hypoxemia and cardiac arrhythmia in cystic fibrosis
A.H. Gifford  Journal of Cystic Fibrosis 
M. C. Alanin, K. G. Nielsen, C. von Buchwald, M. Skov, K. Aanaes, N
Differences in prevalence and treatment of Pseudomonas aeruginosa in cystic fibrosis centres in Denmark, Norway and Sweden  Per Kristian Knudsen, Hanne.
Economic effects of an eradication protocol for first appearance of Pseudomonas aeruginosa in cystic fibrosis patients: 1995 vs. 2009  Yolanda P. Lillquist,
Effectiveness of inhaled tobramycin in eradicating Pseudomonas aeruginosa in children with cystic fibrosis  Sanja Stanojevic, Valerie Waters, Joseph L.
Physiologic endpoints for clinical studies for cystic fibrosis
E. Tschiedel, H. Grasemann, F. Ratjen  Journal of Cystic Fibrosis 
Sally H. Pattison, Geraint B. Rogers, Martin Crockard, J
Prevalence and risk factors for recovery of filamentous fungi in individuals with cystic fibrosis  Christopher R. Sudfeld, Elliott C. Dasenbrook, William.
Novel concepts in evaluating antimicrobial therapy for bacterial lung infections in patients with cystic fibrosis  Geraint B. Rogers, Lucas R. Hoffman,
Antimicrobial activity of fosfomycin and tobramycin in combination against cystic fibrosis pathogens under aerobic and anaerobic conditions  Gerard McCaughey,
Association between the introduction of a new cystic fibrosis inhaled antibiotic class and change in prevalence of patients receiving multiple inhaled.
Australian epidemic strain pseudomonas (AES-1) declines further in a cohort segregated cystic fibrosis clinic  Amanda L. Griffiths, Danielle F. Wurzel,
Nutritional decline in cystic fibrosis related diabetes: The effect of intensive nutritional intervention  H. White, K. Pollard, C. Etherington, I. Clifton,
Chronic Stenotrophomonas maltophilia infection and mortality or lung transplantation in cystic fibrosis patients  Valerie Waters, Eshetu G. Atenafu, Annie.
Segregation of children with CF diagnosed via newborn screening and acquisition of Pseudomonas aeruginosa  Karen O. McKay, Peter J. Cooper, Peter P. van.
Michael D. Parkins, R. Andres Floto  Journal of Cystic Fibrosis 
Trends in pathogens colonising the respiratory tract of adult patients with cystic fibrosis, 1985–2005  F.A. Millar, N.J. Simmonds, M.E. Hodson  Journal.
C. Van de Kerkhove, P. C. Goeminne, M. Kicinski, T. S. Nawrot, N
Comparing age of cystic fibrosis diagnosis and treatment initiation after newborn screening with two common strategies  Don B. Sanders, Huichuan J. Lai,
H. White, A.M. Morton, S.P. Conway, D.G. Peckham 
J.E. Spahr, R.B. Love, M. Francois, K. Radford, K.C. Meyer 
Prevalence and antimicrobial susceptibility of microorganisms isolated from sputa of patients with cystic fibrosis  Giuseppe Valenza, Dennis Tappe, Doris.
Risk factors for Mycobacterium abscessus infection in cystic fibrosis patients; a case– control study  Maarten Verregghen, Harry G. Heijerman, Monique.
C. R. Hansen, T. Pressler, K. G. Nielsen, P. Ø. Jensen, T
G.C. Schito  Clinical Microbiology and Infection 
The role of respiratory viruses in adult patients with cystic fibrosis receiving intravenous antibiotics for a pulmonary exacerbation  C. Etherington,
CFTR modulators and pregnancy: Our work has only just begun
Exercise-induced hypoxemia and cardiac arrhythmia in cystic fibrosis
Treatment intensity and characteristics of MRSA infection in CF
Michael W. Konstan, Jeffrey S. Wagener, Donald R. VanDevanter, David J
Lutz Goldbeck, Sven Zerrer, Tim G. Schmitz  Journal of Cystic Fibrosis 
Khin M. Gyi, Margaret E. Hodson, Magdi Y. Yacoub 
David Adeboyeku, Sandra Scott, Margaret E. Hodson 
Increasing resistance of the Liverpool Epidemic Strain (LES) of Pseudomonas aeruginosa (Psa) to antibiotics in cystic fibrosis (CF)—A cause for concern? 
Changing thresholds and incidence of antibiotic treatment of cystic fibrosis pulmonary exacerbations, 1995–2005  Donald R. VanDevanter, Eric P. Elkin,
Localized Mycobacterium avium complex infection in a patient on HAART
Robert P. Thomen, Laura L. Walkup, David J. Roach, Zackary I
Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience  C.R.
Presentation transcript:

Chronic Mycobacterium abscessus infection and lung function decline in cystic fibrosis  Charles R. Esther, Denise A. Esserman, Peter Gilligan, Alan Kerr, Peadar G. Noone  Journal of Cystic Fibrosis  Volume 9, Issue 2, Pages 117-123 (March 2010) DOI: 10.1016/j.jcf.2009.12.001 Copyright © 2009 European Cystic Fibrosis Society. Terms and Conditions

Fig. 1 Prevalence of NTM species and associated pathogens. A) Relative distribution of NTM species (n=536). M. abs=M. abscessus, M. avi=M. avium complex, and M. gor=M. gordonae. Others included all other NTM, predominantly unidentified species (n=33) but small numbers of M. fortuitum (n=3), M. B) Frequency of culture positivity for various CF pathogens in bacterial/fungal cultures associated with NTM+ or NTM− AFB cultures. P. aer=P. aeruginosa, S. aur=Staphylococcus aureus, S. mal=S. maltophilia,and A. xyl=Achromobacter xylosoxidans. A. fum=Aspergillus fumigatus. *p<0.05 NTM+ vs. NTM− by Chi-squared analysis. Journal of Cystic Fibrosis 2010 9, 117-123DOI: (10.1016/j.jcf.2009.12.001) Copyright © 2009 European Cystic Fibrosis Society. Terms and Conditions

Fig. 2 Age distribution and annual prevalence of NTM infection. Prevalence was calculated form records of 1216 CF patients with at least one microbiological culture obtained from a single university CF center from 2000 to 2007. A) For each year of age, the percentage of patients with at least one AFB culture attempt (squares) was determined, as was the percentage of patients with at least one culture positive for NTM among all patients (triangles) and AFB screened patients (circles). Older patients were more likely to have both AFB culture attempts and NTM isolated from AFB cultures. B) For each calendar year of the study, the percentage of patients with at least one AFB culture attempt (squares) and at least culture positive for NTM among all patients (triangles) and AFB screened patients (circles) was determined. Among all patients, the percentage of AFB cultures and NTM positive cultures increased over time, although the percentage of NTM positive cultures among AFB screened patients remained relatively constant. Journal of Cystic Fibrosis 2010 9, 117-123DOI: (10.1016/j.jcf.2009.12.001) Copyright © 2009 European Cystic Fibrosis Society. Terms and Conditions

Fig. 3 Prevalence of NTM in patients with longitudinal clinical data. The subset of CF patients with at least three AFB culture attempts and at least 3years of lung function data was examined (n=271). Within this group, the percentage of patients with at least one AFB culture attempt (squares) and at least one positive culture for NTM among all patients (triangles) and those patients with least one AFB culture attempt (circles) was determined. As with the larger group, the percentage of patients with AFB cultures and NTM positive cultures increased over time, although the percentage of patients with AFB culture attempts that were NTM positive was relatively constant. Journal of Cystic Fibrosis 2010 9, 117-123DOI: (10.1016/j.jcf.2009.12.001) Copyright © 2009 European Cystic Fibrosis Society. Terms and Conditions

Fig. 4 Model of changes in FEV1 % predicted over time in chronic NTM infection, adjusted for confounders. Using the data from Table 2, a model of lung function decline over time was generated for groups of patients with no NTM infection (solid line) and chronic M. abscessus infection (dashed line) after adjustment for potential confounders. This model demonstrates the worsening decline in lung function over time in the chronic M. abscessus infection group. Journal of Cystic Fibrosis 2010 9, 117-123DOI: (10.1016/j.jcf.2009.12.001) Copyright © 2009 European Cystic Fibrosis Society. Terms and Conditions